F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. From Wikipedia
The bid centers on Phase 3 FGF21 analog pegozafermin to strengthen Roche’s cardiometabolic franchise.